Ladenburg Thalmann Financial Services’s Bio-Path Holdings Inc BPTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$4K Sell
26
-25
-49% -$4.7K ﹤0.01% 4903
2019
Q3
$10K Hold
51
﹤0.01% 4410
2019
Q2
$14K Hold
51
﹤0.01% 4281
2019
Q1
$21K Hold
51
﹤0.01% 3970
2018
Q4
$4K Hold
51
﹤0.01% 4705
2018
Q3
$12K Hold
51
﹤0.01% 4202
2018
Q2
$41K Hold
51
﹤0.01% 3399
2018
Q1
$41K Hold
51
﹤0.01% 3399
2017
Q4
$42K Buy
51
+25
+96% +$32.1K ﹤0.01% 3348
2017
Q3
$37K Buy
+26
New +$35.7K ﹤0.01% 3317
2016
Q2
Sell
-1
Closed -$8K 4866
2016
Q1
$8K Hold
1
﹤0.01% 3852
2015
Q4
$4K Hold
1
﹤0.01% 4162
2015
Q3
$3K Hold
1
﹤0.01% 4171
2015
Q2
$3K Hold
1
﹤0.01% 4261
2015
Q1
$5K Buy
+1
New +$8.41K ﹤0.01% 3999

Other funds holding BPTH

Ladenburg Thalmann Financial Services's BPTH Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Bio-Path Holdings Inc (BPTH) stake by 49% in Q4 2019, selling an estimated $4.7K and leaving 26 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4903.

Ladenburg Thalmann Financial Services first reported a position in BPTH in Q1 2015 and has held it in 15 quarters since. The position peaked at $42K in Q4 2017. 15 funds tracked by Wall St. Rank hold BPTH as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 26 shares of Bio-Path Holdings Inc worth $4K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 25 Bio-Path Holdings Inc shares in Q4 2019, an estimated $4.7K.
  • Bio-Path Holdings Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4903 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Bio-Path Holdings Inc in Q1 2015 and has held it in 15 quarters since.
  • Ladenburg Thalmann Financial Services's Bio-Path Holdings Inc position peaked at $42K in Q4 2017.
  • 15 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.